乳化SPTAN1通过促进NOTCH1/HES1激活和免疫抑制来加速肝细胞癌的进展
Zengbin Wang1, Dongjie Ye2, Linqing Wu1
1Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, 350122, China.
阿尔法II谱乳化 (SPTAN1-kla) 通过改变细胞信号和免疫反应,驱动与乙型肝炎病毒相关的肝癌. 准SPTAN1-kla对治疗肝细胞癌 (HCC) 有希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 非红细胞αII谱 (SPTAN1) 对神经元功能至关重要,但其致癌作用尚不清楚.
- 由乙型肝炎病毒 (HBV) 驱动的肝细胞癌 (HCC) 是一个重大的全球健康挑战.
研究的目的:
- 研究SPTAN1乳化 (SPTAN1-kla) 在与HBV相关的HCC中的作用.
- 阐明SPTAN1-kla促进HCC进展的分子机制.
主要方法:
- 在HBV阳性HCC组织中分析SPTAN1乳化.
- 识别介于SPTAN1乳酸和分乳酸的酶 (AARS1和HDAC1).
- 研究SPTAN1-kla对细胞信号通路 (NOTCH1/HES1,COX2/mPGES1) 和免疫细胞透的影响.
主要成果:
- 在HBV阳性HCC中,SPTAN1乳发生在K1952和K1957时,由AARS1介导,并由HDAC1.1逆转.
- 乙型肝炎病毒感染促进SPTAN1-kla,导致核转移和NOTCH1/HES1信号的激活,推动HCC的扩散.
- SPTAN1-kla通过NOTCH1/HES1和COX2/mPGES1增强了前列腺素E2生物合成,增加了耗尽的CD8+ T细胞透.
- 针对SPTAN1-kla的抑制性酸可在临床前模型中降低HCC瘤生长.
结论:
- SPTAN1-kla是HBV相关HCC的新型瘤驱动剂,通过代谢重编程和免疫调节促进瘤生长.
- 准SPTAN1-kla为HCC的精准医学干预提供了一个潜在的治疗策略.
更多相关视频
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
相关概念视频
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs
Regulation of Angiogenesis and Blood Supply
The JAK-STAT Signaling Pathway
